Rheumatic heart disease in children: from clinical assessment to therapeutical management.

Abstract

Rheumatic heart disease is still a relevant problem in children, adolescents and young adults. Molecular mimicry between streptococcal and human proteins has been proposed as the triggering factor leading to autoimmunity and tissue damage in rheumatic heart disease. Despite the widespread application of Jones' criteria, carditis is either underdiagnosed or overdiagnosed. Endocarditis leading to mitral and/or aortic regurgitation influences morbidity and mortality of rheumatic heart disease, whilst myocarditis and pericarditis are less significant in determining adverse outcomes in the long-term. Strategy available for disease control remains mainly secondary prophylaxis with the long-acting penicillin G-benzathine.

• Authors: G De Rosa, M Pardeo, A Stabile, D Rigante
• Journal: European review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) 2006 May-Jun Vol. 10 Issue 3 Pg. 107-10 ISSN: 1128-3602 [Print] Italy
• PMID: 16875042 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Bacterial Agents
• Anti-Inflammatory Agents
• Cardiotonic Agents
• Cephalosporins
• Salicylates
• Digoxin
• Penicillin G
• Prednisone

Topics

• Adolescent
• Anti-Bacterial Agents (therapeutic use)
• Anti-Inflammatory Agents (therapeutic use)
• Cardiotonic Agents (therapeutic use)
• Cephalosporins (therapeutic use)
• Child
• Digoxin (therapeutic use)
• Endocarditis, Bacterial (drug therapy, etiology, prevention & control)
• Humans
• Myocarditis (drug therapy, etiology, prevention & control)
• Penicillin G (therapeutic use)
• Pericarditis (drug therapy, etiology, prevention & control)
• Practice Guidelines as Topic
• Prednisone (therapeutic use)
• Rheumatic Heart Disease (drug therapy, etiology, prevention & control)
• Salicylates (therapeutic use)
• Secondary Prevention
• Streptococcal Infections (complications, prevention & control)
• Time Factors